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Abstract
Here we report an enhanced throughput method for the diagnosis of human exposure to sulfur 
mustard (HD). A hydroxyethylthioethyl (HETE) ester adducted tripeptide, produced by pronase 
digestion of human serum albumin, was selected as the quantitative exposure biomarker. Cibacron 
Blue enrichment was developed from an established cartridge method into a 96-well plate format, 
increasing throughput and ruggedness. This new method decreased sample volume by 2.5-fold. 
Addition of a precipitation and solid-phase extraction concentration step increased the sensitivity 
of the method. With the conversion to a 96-well plate and optimization of chromatography, the 
method resulted in a 3-fold decrease in analysis time. Inclusion of a confirmation ion has 
increased specificity. The method was found to be linear between 0.050 and 50 µM HD exposure 
with precision for both quality control samples ≤6.5% relative standard deviation (RSD) and 
accuracy >96%. The limit of detection (3So) was calculated to be ∼0.0048 µM, an exposure value 
similar to the HETE-albumin adduct method first described by Noort(1-2) which used protein 
precipitation to isolate albumin. A convenience set of 124 plasma samples from healthy 
unexposed individuals was analyzed using this method to assess background levels of exposure to 
HD; no positive results were detected.
Scheme 1 (abstract)
Cibacron blue and protein precipitation method for extracting albumin from serum/plasma
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INTRODUCTION
Sulfur mustard (2,2’-dichloroethyl sulfide) is a potent and persistent vesicant which 
produces painful blisters, or vesicles, upon exposure. Sulfur mustard can penetrate clothing 
forming blisters on protected areas of the skin as well as on exposed areas.(3) Eye and lung 
tissue are even more sensitive than skin to exposure; sulfur mustard can cause temporary 
blindness as well as injury to the respiratory tract. In addition, sulfur mustard is highly 
mutagenic and carcinogenic, readily alkylating and crosslinking guanine residues within 
DNA(4) which may result in possible long term health effects. Sulfur mustard was first used 
as a military weapon during World War I (WWI) and is attributed to over 80% of the 
chemical casualties reported.(5)
Since WWI there have been several suspected and confirmed uses of sulfur mustard. The 
most well documented use took place during the Iran-Iraq conflict in the 1980s(6–9) in 
which Iraq used sulfur mustard on Iranian soldiers. Iraq also used sulfur mustard against its 
own Kurdish population.(10) In 1993, the Chemical Weapons Convention (CWC) was 
signed; the treaty prohibits the production and stockpiling of chemical weapons and 
provides a timeline for destruction of stockpiled chemical weapons. Sulfur mustard agent 
(distilled sulfur mustard, HD) is listed as a vesicant on Schedule 1 of the CWC and is 
defined as having limited or no use outside of chemical warfare. Despite efforts by the 
Organisation for the Prohibition of Chemical Weapons (OPCW), which oversees 
enforcement of the CWC, HD stockpiles still exist around the world and pose a public health 
risk.
The use of the nerve agent sarin in Matsumoto in June 1994 and in the Tokyo subway in 
March 1995 by members of the doomsday cult Aum Shinrikyo highlighted the possibility of 
chemical weapons being used in an act of terrorism.(11) In response to these possible public 
health risks, the Laboratory Response Network (LRN) was established in 1999 within the 
United States. This laboratory network includes representative state and local health 
department laboratories across the nation in addition to the Centers for Disease Control and 
Prevention and can assess exposure to a wide range of chemical (LRN-C) and biological 
agents (LRN-B). The LRN-C has responded to several small scale incidents involving sulfur 
mustard since its establishment including clam fisherman exposed after dredging up a 
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discarded munition off of the northeastern US coast(12) and American military personnel 
exposed during demilitarization of munitions.(13)
Diagnosing human exposure to any chemical is typically assessed by measuring its level in 
blood, its metabolite(s) in urine, or its covalent modification(s) to proteins or DNA.(14) 
Sulfur mustard can be measured in blood by gas chromatography (GC), but is limited to 
measurement within a few hours after exposure.(15–16) Sulfur mustard is rapidly 
hydrolyzed in aqueous environments, losing a chlorine atom and forming a very reactive 
episulfonium ion intermediate which can be quickly metabolized. Black et al.(17) were able 
to detect β-lyase metabolites in human casualties up to 13 days following a vesicant 
exposure. The most sensitive measurement of sulfur mustard metabolites is based on tandem 
mass spectrometry (MS/MS), either coupled to GC(18–20) or liquid chromatography (LC).
(21) Analysis of metabolites by GC-MS/MS has been used to verify sulfur mustard 
exposure.(22–23)
The episulfonium intermediate also reacts with a wide range of biological nucleophiles. 
Reactions of the episulfonium intermediate with carboxyl groups form hydroxyethyl 
thioethyl (HETE) esters while reactions with -SH groups form thio-ethers (Figure 1).(24–25) 
The alkylating property of sulfur mustard extends the time possible for retrospective 
determination of exposure; the exact time frame for analysis is reflective of the natural 
turnover of the alkylated macromolecule in the body. Several methods have been developed 
based on DNA adducts including an immunochemical method that detects adducts to N7-
guanine from blood cells.(26) Methods for measuring sulfur mustard adducts to proteins 
have also been developed including the following: immunochemical detection of sulfur 
mustard adducts to keratin;(27) GC-MS and LC-MS/MS determination of adducts to the N-
terminal valine and histidine residues of hemoglobin;(28–29) LC-MS/MS determination of 
adduction to cysteine-34 (Cys-34) of serum albumin;(1–2) LC-multiple reaction monitoring 
(MRM) validation of sulfur mustard and nitrogen mustard adducts to the Cys-34 residue of 
serum albumin;(30) and GC-MS detection of adducts to blood proteins.(31–33) These 
adduct methods have been successfully applied for retrospective determination of sulfur 
mustard exposure. The keratin adduct method and the GC-MS hemoglobin adduct method 
were both used to verify sulfur mustard exposure of two Iranian victims using samples taken 
over three weeks post-exposure;(34) the albumin adduct method was used to verify sulfur 
mustard exposure of several Iranian victims of the Iran-Iraq conflict from samples collected 
8–9 days post-exposure;(1) and the albumin adduct and blood adduct methods were used to 
verify sulfur mustard exposure after an accidental exposure using samples taken over 40 
days post-exposure.(13, 35)
Today, sulfur mustard stockpiles still exist without a known antidote for exposure. Given the 
instability of regions around the world in possession of known chemical weapon stockpiles, 
and the likelihood of delayed sample collection, a method with the widest window for 
analysis post-exposure is critical. Clearly, the adduct methods provide a powerful tool for 
long-term assessment of sulfur mustard exposure. One of the limitations to some of the 
protein adduct methods previously published is the laborious protein purification process. 
The original albumin adduct method was based on serial protein precipitation.(1) This 
method was further improved by addition of Cibacron Blue cartridge enrichment of albumin,
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(2) although the purification scale used still required serial processing of samples. Despite 
improving the sample processing procedure, converting the method to Cibacron Blue 
purification resulted in an overall decrease in sensitivity. Here we report an enhanced 
throughput method for detecting sulfur mustard adducts to albumin which utilizes Cibacron 
Blue enrichment in a 96-well plate format. The reported method has increased 
reproducibility, throughput, and specificity with increased sensitivity to the previously 
reported albumin adduct method.(2)
MATERIALS AND METHODS
Chemicals and Materials
Monobasic sodium phosphate, dibasic sodium phosphate, potassium chloride, 6.1 M 
trichloroacetic acid solution (TCA, from MP Biomedicals), Optima acetone, ammonium 
bicarbonate, HPLC-grade water, HPLC-grade acetonitrile, and LC-MS-grade formic acid 
were purchased from Fisher Scientific (Hanover Park, IL). Pronase Type XIV from 
Streptomyces griseus was purchased from Sigma-Aldrich Chemical Co. (Lot 45F-0545; St. 
Louis, MO). Pall Acroprep® 96-well 0.45 µm filter plates, Pierce® Blue Albumin Removal 
kits, Nunc® fritted 96-well plates, Millipore MultiScreen® Ultracel-10 filter plates, 
Eppendorf 96-well PCR plates, and 1 mL and 2 mL 96-well receiving plates were purchased 
from Fisher Scientific (Hanover Park, IL). Strata® C18-E 96-well plates (100 mg/well, 55 
µm, 70 Å) and Kinetex® XB-C18 (100 × 2.1 mm, 2.6 µm, 100 Å) columns were purchased 
from Phenomenex (Torrance, CA). HD-spiked plasma samples and HETE-adducted CPF 
peptides were generated at The Netherlands Organisation for Applied Scientific Research 
(TNO; Rijswijk, Netherlands).(1) Plasma samples for dilution of calibrators and quality 
control (QC) samples were purchased from Tennessee Blood Services (Memphis, TN). 
Additionally, a convenience set of 124 plasma specimens from healthy individuals with no 
known exposure to sulfur mustard was also purchased from Tennessee Blood Services for 
assessing method background.
Enrichment of Albumin
After thawing, plasma samples were centrifuged in microcentrifuge tubes at 10,000 xg for 5 
min at 20°C to remove particulates. Two hundred microliters of plasma was spiked with 20 
µL internal calibrator (10 µM D8 sulfur mustard-spiked plasma from TNO) and diluted with 
800 µL 50 mM sodium phosphate buffer (NaHPO4), pH 7.0. Seven hundred fifty microliters 
of the diluted plasma was filtered through a Pall AcroPrep® 0.45 µm 96-well plate at 2250 
xg for 5 min at 20°C for further clarification.
For human serum albumin (HSA) enrichment, two Pierce Blue Albumin SwellGel® discs 
were used for each plasma sample. Discs were rehydrated in fritted 96-well plates with 760 
µL water and centrifuged at 2250 xg for 2 min at 20°C. Five hundred microliters of the 
filtered sample was loaded onto the swell gel layer, vortexed briefly, and centrifuged as 
above. The flow-through was reloaded, vortexed, and centrifuged as above. Captured 
proteins were washed with 500 µL 50 mM NaHPO4 (pH 7.0) with vortexing and 
centrifugation as above. Bound proteins were eluted with 600 µL 50 mM NaHPO4/1.5 M 
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KCl (pH 7.0) three times (1800 µL total volume of enriched albumin) with vortexing and 
centrifugation as above.
Digestion of Enriched HSA
For effective digestion, the enriched albumin protein was desalted by TCA/acetone 
precipitation. Sixteen hundred microliters of enriched albumin was precipitated in two 
separate wells of a 96-well plate (800 µL per well). Two hundred microliters 6.1 N TCA was 
added to each 800 µL of eluted protein. The plate was stored at 4°C for 30 min and 
centrifuged at 3000 xg for 5 min at 20°C. TCA was aspirated, and the pellet was washed 
twice with 400 µL ice cold acetone with centrifugation as above. After aspirating the second 
wash, the pellet was allowed to air dry for 5 min at room temperature and solubilized in 300 
µL of 50 mM ammonium bicarbonate at 37°C for 30 min with intermittent shaking for 10 
sec every minute. Digestion was initiated by adding 110 µL of 10 mg/mL pronase in 50 mM 
ammonium bicarbonate to each well, and protein was digested at 37°C for 90 minutes with 
intermittent shaking for 10 sec every minute.
Concentration of Digested Peptides
To remove any remaining pronase, the digest was size fractionated using a 10 kDa MWCO 
96-well filter plate with centrifugation at 3000 xg for 90 min at 20°C. The eluent containing 
peptides was diluted with 500 µL 50 mM ammonium bicarbonate and the split digest sample 
recombined. Peptides were then concentrated using a 96-well C18-E SPE plate (100 mg/
well, 55 µm, 70 Å). The plate was conditioned with 2 mL acetonitrile followed by 2 mL 
0.2% formic acid by vacuum filtration. The entire sample was loaded onto the SPE plate and 
washed with 2 mL 0.2% formic acid by vacuum filtration. Peptides were eluted with 1.8 mL 
40% acetonitrile/0.2% formic acid two times into separate wells by vacuum filtration (3.6 
mL total volume of extracted peptides in two wells). The eluent was blown to dryness using 
a TurboVap-96 (Biotage, Charlotte, NC) at 50°C with nitrogen. The sample was 
reconstituted and recombined using 150 µL 2% acetonitrile/0.2% formic acid, transferred to 
an Eppendorf 96-well PCR plate, and heat sealed.
Liquid Chromatography-Tandem Mass Spectrometry
Peptide samples were analyzed using an Agilent 1200 liquid chromatograph (Santa Clara, 
CA) connected to an AB Sciex 4000 QTRAP® mass spectrometer (MS) (Framingham, 
MA). Fifty microliters of the peptide extract was separated by reversed-phase 
chromatography using a Phenomenex Kinetex® XB-C18 (100 × 2.1 mm, 2.6 µm, 100 Å) 
column with a 100 µL sample loop. Mobile phase A consisted of 0.2% formic acid in 2% 
acetonitrile (aq). Mobile phase B consisted of 0.2% formic acid in 80% acetonitrile (aq). 
Separation was performed at 30°C at 200 µL/min. The elution program consisted of isocratic 
conditions at 80% mobile phase A for 6 min, followed by a wash with 100% mobile phase B 
for 1.5 min, and re-equilibration back to 100% mobile phase A for 8.5 min.
Eluted peptides were analyzed on the MS using a Turbo Ion Spray source in positive ion 
mode. Data were acquired with Analyst 1.4.2 using Selected Reaction Monitoring (SRM), 
monitoring two transitions each for both the unlabeled and labeled peptide with a 200 ms 
dwell time. The fragment ions monitored represent the protonated adduct [HETE + H]+ for 
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quantitation and the protonated adduct with the cysteine sulfur atom attached [HETE-S + 
H]+ for confirmation (Figures 2 and 3). Nitrogen was used as the collision gas, and 
transitions were optimized for collision energy (CE) and collision exit potential (CXP). 
Optimized parameters are listed in Table 1. The source parameters were optimized by post-
column infusion of 1 ppm H8-[HETE]-CPF peptide at 10 µL/min and mixing with 80% 
mobile phase A running at 190 µL/min. The source capillary was optimized at 175°C and 
ion spray voltage was optimized at 5500 eV. Declustering potential and entrance potential 
were the same for both light and heavy adducted peptides and set to 65 eV and 12 eV 
respectively.
Calibration Curve and QCs
High concentration HD-spiked plasma samples were generated by adding a stock solution of 
HD solubilized in acetonitrile to plasma, resulting in a final concentration of HD in plasma 
at 0.1 µM, 1 µM, 10 µM, and 100 µM. Calibrators and QC samples were generated by 
dilution of these high concentration H8-HD-spiked plasma materials (0.1 µM, 1 µM, 10 µM, 
and 100 µM) with unexposed plasma. All calibrators and QC samples were then processed at 
the same time as the individual patient plasma samples used for determining background 
interference levels in healthy individuals. The final calibration curve ranged three orders of 
magnitude from 0.05 µM to 50 µM (0.05 µM, 0.08 µM, 0.1 µM, 0.5 µM, 1 µM, 5 µM, 10 
µM, and 50 µM). The QC-Low and QC-High samples were prepared to 0.25 µM and 6.25 
µM, respectively. A QC blank sample was prepared using 200 µL of unexposed plasma 
spiked with the same amount of acetonitrile used in generating the HD-spiked plasma 
materials. It is important to clarify that the values quantified in this method represent the 
concentration of HD in blood which results in the measured adducted peptide response. This 
method does not report the true concentration of adducted peptide since HD most likely 
binds to unmonitored proteins. The method was characterized by running no more than two 
calibration curves per day, each with a QC set, over an eight week period by two individual 
analysts.
RESULTS
The current method for assessing sulfur mustard adducts based on Cibacron Blue cartridge 
enrichment of albumin entails several manual cartridge steps and is not optimal for parallel 
processing of samples. Our interest in increasing throughput and ease of sample preparation 
led us to investigate alternative enrichment strategies for albumin. The Pierce® Blue 
Albumin Removal Kit includes Cibacron Blue discs that are readily transferred to a 96-well 
plate and have sufficient binding capacity for albumin adduct analysis. We assessed 
recovery of the Cibacron Blue cartridge and SwellGel® discs by comparing the response of 
the 470 → 105 m/z transition from equal column loadings of three concentrations of H8-
HD-spiked plasma preparations and found both to be equivalent.
In addition to searching for alternative albumin enrichment strategies, we also explored 
approaches for desalting. We investigated 96-well desalting plates (Zeba Spin Desalting 
Plate, Fisher Scientific, Hanover Park, IL), protein precipitation plates (Pierce, Fisher 
Scientific, Hanover Park, IL), and TCA/acetone precipitation in a 96-well format using 
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centrifugation by comparing the response of the 470 → 105 m/z transition from equal 
column loadings of five concentrations of H8-HD-spiked plasma preparations. Although the 
desalting plate resulted in increased sensitivity for the lower concentration spiked plasma 
samples, the response was not linear. We achieved similar results for the two precipitation 
procedures; both were linear over three orders of magnitude. Due to cost and concerns with 
effective resolubilization on the protein precipitation plate, we chose the TCA/acetone 
precipitation method for desalting the Cibacron Blue enriched albumin preparation.
While optimizing the various sample preparation procedures, we found that the sensitivity of 
the Cibacron Blue cartridge based method in our hands with the most recent calibrator 
materials was about 10-fold less than originally reported. The original albumin adduct 
method,(1) based on a series of protein precipitation steps, is reported to have a limit of 
quantitation of 0.0045 µM HD exposure.(2) We were interested in increasing the sensitivity 
of the Cibacron Blue method to be comparable with the original precipitation based albumin 
adduct method. Including a C18 solid phase extraction step using a Phenomenex® Strata 
C18-E 96-well plate (100 mg/well, 55 µm, 70 Å) increased sensitivity approximately 6-fold.
Chromatography for the Cibacron Blue cartridge based method varies between labs but 
typically utilizes a 150 × 1 mm column with a 30–60 min gradient at 50 µL/min. We were 
interested in decreasing the run time to increase throughput. We chose to decrease the 
column length and increase column diameter to accommodate the pressure associated with 
an increased flow rate. With only one analyte monitored in this method, we chose to utilize a 
step gradient separation. We were able to inject 50 µL of extracted sample without any loss 
of peak shape or retention time. The increased sample volume directly related to increased 
sensitivity. Figure 4 shows a typical chromatogram for the four transitions acquired in the 
method. The adducted pronase peptide ([HETE]-CPF) elutes at approximately 6 min.
Inherent to this method is the specificity of the quantitation ion. The transition monitored for 
quantitation represents the loss of CPF from the protonated adduct (470 → 105 m/z). This 
product ion mass for [HETE + H]+ (105 m/z) is unique when considering the typical 
fragment ions generated by peptides in the low m/z range. However, to increase specificity 
of the method, a confirmation ion was included in the analysis. The transition monitored for 
confirmation represents the loss of the protonated adduct with the cysteine sulfur atom 
attached (470 → 137 m/z). Similar to the quantitation ion, the product ion mass for [HETE-
S + H]+ (137 m/z) is also unique among the typical fragment ions generated by peptides in 
the low m/z range. The confirmation ion ratio (the area of the confirmation ion peak divided 
by that of the quantitation ion peak, CIR) was found to be reproducible. The within-run 
average CIR for the calibrators ranged from 0.353 to 0.412 with relative standard deviations 
(RSDs) ranging from 3.04 – 16.81%. Specificity of the method was confirmed by analyzing 
a convenience set of 124 individual plasma specimens from healthy individuals with no 
known exposure to sulfur mustard. No background/interference peaks were measured in any 
of the 124 unexposed specimens at the corresponding retention time of [HETE]-CPF.
Since a large volume and high concentration of extracted peptide is analyzed by LC-MS/MS 
for this method, matrix effects were assessed using post-column infusion of 1 ppm H8-
[HETE]-CPF at 10 µL/min and monitoring the quantitation and confirmation ion transitions 
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after 50 µL injection of the aforementioned convenience set plasma specimens.(36) At the 
expected retention time of [HETE]-CPF, there is approximately a 2-fold decrease in signal. 
Dilution of the plasma samples four-fold eliminates any observed ion suppression but also 
decreases overall signal intensity of the internal calibrator. As the matrix effect was not 
substantial, we chose to accept this level of ion suppression. Samples were run undiluted 
with the caveat that the source and Q0 would need to be cleaned on a regular basis.
The limit of detection (LOD) was estimated by calculating 3So for both quantitation and 
confirmation ions.(37) The LOD estimate for the quantitation ion is 0.0048 µM. The lowest 
reportable limit (LRL) is however set to be the concentration of the analyte in the lowest 
calibrator in accordance with the Clinical Laboratory Improvement Amendments (CLIA) 
regulations, laboratory requirements, 42 C.F.R. Part 493 (2004). For the new enhanced 
throughput method, the LRL corresponds to a 0.050 µM HD exposure which is the lowest 
calibrator that gives a reproducible confirmation ion signal. From the analysis of 20 curves, 
the mean for the lowest calibrator was calculated to be 0.049 µM with an accuracy of 97.5% 
and precision of 9.1% RSD.
Calibrator concentrations were chosen to cover a wide range of possible exposure levels. 
The [HETE]-albumin adduct assay has only been used to assess the extent of exposure from 
a small number of exposed individuals. Blood samples taken from nine Iranian casualties 
during the Iran-Iraq war had adduct levels ranging from 0.4 to 1.8 µM HD-exposure.(1) All 
patients had skin injuries consistent with sulfur mustard exposure. Blood samples taken from 
two ordnance technicians exposed to sulfur mustard during destruction of a WWI munition 
were also found to have [HETE]-albumin adducts. One patient, with chemical burns over 
approximately 6.5% of the body had albumin adduct levels measured at 0.354 µM HD-
exposure two days post-exposure. The other patient, who presented with only one small 
blister, had albumin adduct levels averaging 0.017 µM HD-exposure two days post-
exposure.(13)
Due to the extremely low tolerance for false positives associated with reporting results from 
this method, we selected the lowest calibrator based on a combination of specificity and 
sensitivity rather than entirely on sensitivity. The lowest calibrator was chosen based on the 
HD-spike concentration that approached the limit of quantitation of the original albumin 
adduct method (0.0045 µM)(2), yet still permitted integration of the confirmation ion with 
high confidence (S/N = 10). The highest calibrator was chosen based on estimation of the 
HD-spike concentration which would reflect a severe exposure with chemical burns over the 
majority of the body. The highest calibrator concentration represents approximately 2 x 
LD50 (96 hour) in the hairless guinea pig model after intravenous administration of HD.(38) 
The intermediate points were chosen to result in a curve with at least 7 points spanning three 
orders of magnitude. For ease of dilution of the spiked-plasma stock solutions, we chose 
multiples of 2 and 5 to span the calibration range, adding one additional point at the low end 
of the curve. QC concentrations were selected to fall in the middle of the curve between the 
third and fourth calibrator (QC-Low) and sixth and seventh calibrator (QC-High).
Individual curves were analyzed using a linear regression with 1/x weighting. For 20 curves, 
the average slope was 1.0114 ± 0.1102 (slope ± standard deviation), intercept was 0.0037 ± 
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0.0088, and correlation coefficient value was 0.9997 ± 0.0003. Based on the average 
correlation coefficient and its calibrator deviation for 20 curves, the method is linear over 
three orders of magnitude.
Precision was assessed by calculating the RSD for 20 measurements of the calibrators and 
QC samples. True accuracy cannot be assessed due to the indirect measurement of chemical 
exposure. However, accuracy can be inferred by comparing the average calculated value to 
the known spike value for the calibrators and QC samples over 20 measurements. Table 2 
depicts the mean, accuracy, and RSD for the calibrators and QC samples. Accuracy for all 
calibrators and QC samples is greater than 95%, with a precision of < 10% RSD. The 20 QC 
measurements were analyzed by Statistical Analysis System (SAS) for random and 
systematic errors based on Westgard Rules (1 3S Rule, 2 2S Rule, R 4S Rule, and 10 x-bar 
Rule).(39) No runs were rejected, and neither QC-Low nor QC-High results fell outside of 2 
standard deviations (data not shown).
DISCUSSION
We have presented modifications to the Cibacron Blue cartridge based method(2) for 
measuring [HETE]-adducts to albumin which decrease analysis time, increase sensitivity 
despite decreasing plasma amount requirements, increase specificity, and increase 
reproducibility. These improvements include transferring the method to a 96-well plate 
format which was accomplished by changing the albumin enrichment procedure from a GE 
Healthcare HiTrap® Blue cartridge column to Pierce Blue Albumin SwellGel® Discs. 
These discs are readily transferred to a 96-well fritted plate and allow for facile scaling with 
the addition of multiple discs. Although the cartridge column recovers more total protein 
compared to a single gel disc, the current method based on cartridges only analyzes a small 
fraction of the recovered albumin (1/60th). In addition to using a smaller format enrichment 
strategy, we found that we could also decrease the required plasma sample amount (200 µL, 
40% of the current method based on cartridges) and still achieve equivalent sensitivity. 
Reducing sample volume allows us to accept lower sample volumes, enables repeat analysis 
and permits confirmatory work using different methods and laboratories. Young et al.(40) 
investigated several albumin depletion products for albumin enrichment, and though they 
found the HiTrap® Blue column to provide higher albumin purity compared to the 
SwellGel® discs (88% vs 78%), they found slightly higher signal intensities/mg of protein 
recovered by the gel discs when monitoring for both H8- and D8- [HETE]-CPF peptides by 
LC-MS/MS.
This method is a retrospective method to detect exposure to sulfur mustard. Except for a few 
individuals involved in the demilitarization of sulfur mustard munitions, it is not expected 
that the general population would have HETE-adducted albumin in their body. We evaluated 
a convenience set of 124 plasma specimens from a random sampling of individuals and 
found no peak present at the expected retention time of the [HETE]-CPF peptide in any of 
the samples. These results suggest detectable biomarker levels above the LRL and 
confirmed by a CIR within +/− 20% of the average calibrator CIR for the batch would be 
consistent with exposure to sulfur mustard and not a background interference. Running an 
expanded reference range study with a larger number of unexposed patient samples would 
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help to increase the confidence in this assessment. It is important to note, however, that data 
from this assay has to be interpreted in the context of the larger epidemiological picture 
including patient case history, symptoms, and environmental sample data in order to make a 
positive diagnosis of sulfur mustard exposure.
Despite the improved performance of the reported plate based method, all versions of the 
sulfur mustard albumin adduct method to date are limited by the availability of pronase with 
the required activity. In examining new pronase lots from three different vendors, we have 
not been able to identify a lot which results in generation of the adducted tripeptide to the 
same level as the older pronase lots. As pronase is a mixture of proteinases that is typically 
used for complete digestion of proteins into individual amino acids, it is suspected that the 
newer commercially available pronase preparations may be more efficient at digesting 
around a site of adduction, resulting in complete digestion of the tripeptide and loss of our 
biomarker signal.
Changing to a more specific enzyme should resolve the issue of variation in the activity of 
newer lots of pronase and also allow us to measure the percent adduction. With the existing 
pronase digested albumin method, monitoring for the unadducted tripeptide transition (366.2 
→ 263.2) results in high background and a complex chromatogram, making assessment of 
the percent adduction unfeasible. Choosing a more specific enzyme that generates a slightly 
longer peptide should provide the specificity needed to measure both the adducted and 
unadducted peptides and determine percent adduction. In addition, switching to a more 
specific enzyme will decrease the amount of enzyme needed, thereby decreasing the amount 
of background peptides in the peptide extract and possibly decrease ion suppression.
In the field of proteomics, trypsin is the enzyme of choice for protein identification and 
characterization. Trypsin is chosen for several reasons, including its low cost, its specificity 
(C-terminal to lysine and arginine residues), and the sequence information that it provides. 
Trypsin was examined as a possible enzyme for this method initially,(1) however the tryptic 
peptide produced was found to be not as sensitive as the pronase tripeptide and also had 
interferences near its retention time. The decrease in sensitivity is most likely due to the size 
of the peptide produced in digesting HSA with trypsin. Trypsin generates a fairly large 
peptide encompassing the adduction site (21 amino acids), which typically produces several 
multiply charged species by electrospray ionization and spreads out signal intensity. For the 
purposes of quantitation, selection of an enzyme that produces smaller peptides is often 
desirable as it should decrease the charge state distribution and increase sensitivity. High 
specificity chymotrypsin is a good choice for an alternative enzyme for this method, as it 
produces a fairly small peptide (a hexapeptide, LQQCPF) which encompasses the adduction 
site and still should provide the needed specificity. Initial experiments investigating the use 
of chymotrypsin have begun and look promising (data not shown).
Human serum albumin is the most abundant protein in serum/plasma with an average 
concentration of approximately 35–55 mg/mL in blood plasma.(41) The ability to purify 
large amounts of albumin, along with a fairly stable adduction and relatively slow turnover 
rate of approximately 20 days, makes human serum albumin advantageous for retrospective 
determination of chemical exposure.(42) Cysteine residues are one of the most reactive 
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groups in proteins; they are excellent nucleophiles and make good targets for electrophilic 
chemicals.(43) A wide range of electrophiles bind the one available cysteine residue 
(Cys-34). Adducts to Cys-34 have been detected from reactive oxygen species, aldehydes, 
oxiranes, quinones, metal ions, and several drugs(43–45) in addition to vesicants including 
nitrogen mustards and sulfur mustard.(1, 46)
In addition to Cys-34, tyrosine-411 (Tyr-411) is also a reactive residue found on HSA. 
Nerve agents and a wide range of organophosphate pesticides bind Tyr-411.(17, 47–49) 
Similar to the Cys-34 adduction site, chymotrypsin digestion of HSA is predicted to produce 
a suitable peptide encompassing the Tyr-411 adduction site (an octapeptide) for SRM 
monitoring. The combination of the two reactive sites with chymotrypsin digestion makes 
HSA an attractive biomarker to monitor for diverse chemical agents (vesicants and nerve 
agents) at the same time. With the wide range of known chemicals that adduct these two 
sites, and with careful selection of fragment ions, precursor-ion scans can be used to monitor 
for both known and unknown modifications to these sites.(50)
In summary, we have developed and validated an enhanced throughput method for the 
detection of exposure to sulfur mustard by measuring its adducts to human serum albumin. 
The reported method is based on Cibacron Blue enrichment in a 96-well plate format, 
digestion of the purified albumin with pronase, and isotope dilution liquid chromatography 
tandem mass spectrometry analysis of the peptide biomarker of exposure [HETE]-CPF. The 
reported method was designed to provide clinically relevant data regarding exposures to 
sulfur mustard with sufficient specificity, precision, and accuracy. Additional diagnostic 
constraints include an extremely low tolerance for false positive results. Calibrator 
concentrations were chosen to cover a wide range of possible exposure levels, and the 
quantitation range of this analytical method is well below the expected concentrations that 
can result from high level or fatal exposure. Additionally, the incorporation of a 96-well 
plate format has increased our response capabilities in the case of a large scale emergency.
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HETE hydroxyethylthioethyl
HD distilled sulfur mustard
HSA human serum albumin
CPF cysteine-proline-phenylalanine peptide
Cys cysteine
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WWI World War I
CWC Chemical Weapons Convention
OPCW Organisation for the Prohibition of Chemical Weapons
LRN Laboratory Response Network
GC gas chromatography
LC liquid chromatography
MS/MS tandem mass spectrometry





MWCO molecular weight cut-off
HPLC high performance liquid chromatography
SRM selected reaction monitoring
MS mass spectrometer
CE collision energy
CXP collision exit potential
eV electron volt
Q0 Q1, Q3, quadrupoles
QC quality control
CIR confirmation ion ratio
LRL lowest reportable limit
LOD limit of detection
LOQ limit of quantitation
S/N signal-to-noise
LD50 lethal dose 50
RSD relative standard deviation
Tyr tyrosine
uHPLC ultra high performance liquid chromatography
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Adduction of sulfur mustard in mammals. Reactions of the episulfonium intermediate with 
carboxyl groups of biological molecules, including proteins, form hydroxyethylthioethyl 
(HETE) esters.
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The chemical structure of the [HETE]-CPF biomarker. The fragmentation sites for the 
quantitation and confirmation ions are denoted with dashed lines (Cys= cysteine; Pro= 
proline; Phe= phenylalanine).
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Product ion mass spectrum of protonated [HETE]-CPF. The two fragment ions monitored by 
SRM are indicated: the protonated adduct [HETE + H]+ was selected for quantitation and 
the protonated adduct with the cysteine sulfur atom attached [HETE-S + H]+ was selected 
for confirmation. The only other ions of note are the [M + H]+ precursor ion and the y2 ion 
containing Pro and Phe.
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LC-MS/MS chromatogram of [HETE]-CPF from pronase digestion of Cibacron Blue 
enriched albumin from 5 µM H8-HD-spiked plasma sample. Quantitation ion (470 → 105 
m/z), confirmation ion (470 → 137 m/z), internal calibrator (478 → 113 m/z) and internal 
calibrator confirmation ion (478 → 145 m/z) elute at approximately 6 minutes.
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Table 2









Accuracy (%) RSD (%)
Calibrator 1 0.050 0.049 97.5 9.1
Calibrator 2 0.080 0.079 99.2 6.0
Calibrator 3 0.100 0.096 95.6 7.9
Calibrator 4 0.500 0.513 102.5 5.4
Calibrator 5 1.00 1.03 103.0 6.2
Calibrator 6 5.00 5.15 103.0 4.2
Calibrator 7 10.0 10.1 100.6 3.8
Calibrator 8 50.0 49.8 99.6 1.2
QC-Low 0.250 0.259 103.6 6.5
QC-High 6.25 6.21 99.3 6.2
*
The expected and calculated concentration units “µM ExP” are based on in vitro exposure of plasma to HD.
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